6.89
price up icon1.92%   0.13
after-market 시간 외 거래: 6.75 -0.14 -2.03%
loading

Replimune Group Inc (REPL) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
14.74%
71.87
84.29 90.42 79.33 66.02
Operating Income/Loss
14.74%
-71.87
-84.29 -90.42 -79.33 -66.02
Nonoperating Income/Loss
47.36%
0.627
1.191 3.729 5.091 0.254
Income/Loss From Continuing Operations Before Tax
14.27%
-71.24
-83.10 -86.69 -74.24 -65.77
Income Tax Expense/Benefit
-0.311
- - -0.107 0.575
Income/Loss From Continuing Operations After Tax
14.65%
-70.93
-83.10 -86.69 -73.66 -66.34
Net Income/Loss
14.65%
-70.93
-83.10 -86.69 -74.13 -66.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.30%
92.19
91.92 91.52 3.4505 83.50
Diluted Average Shares
0.30%
92.19
91.92 91.52 3.4505 83.50
Basic Earnings Per Share
14.44%
-0.77
-0.90 -0.95 -0.82 -0.79
Diluted Earnings Per Share
14.44%
-0.77
-0.90 -0.95 -0.82 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):